DC Funds, LP
- SEC CIK
- 0001869028
- Latest filing
- Aug 14, 2026
Holdings in Q1 2022
Holdings as of Mar 31, 2022, filed May 13, 2022. Long positions only; changes compare share counts with Q4 2021.
- Positions
- 3
- 0 vs. Q4 2021
- Portfolio value
- $7.70M
- −$9.19M (−54.4%) vs. Q4 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| BRNSBarinthus Biotherapeutics plc. | ADS | 642,204 | $3.34M | 43.4% | 00.0% | Unchanged | History |
| HOWLWerewolf Therapeutics, Inc. | COM | 589,102 | $2.59M | 33.7% | +8,200+1.4% | Added | History |
| TCRXTScan Therapeutics, Inc. | COM | 630,000 | $1.76M | 22.9% | 00.0% | Unchanged | History |